HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

INGN

Inogen, Inc. (NASDAQ)

Healthcare — Medical Devices

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

None 3 analysts
$6.65
+$0.20 (+3.10%)
Target: $12.67 (90.5%)
Sign in to add INGN to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$180.05M
P/E Ratio (TTM)-
Forward P/E-25.58
EPS (TTM)$-0.91
Dividend Yield-
Profit Margin-7.08%
Revenue Growth3.40%
ROE-13.07%
Debt/Equity9.26
Recommendation None
Analyst Target$12.67
Analysts3
Indexes NASDAQ

Technical Indicators

RSI (14)51.7
Beta1.60
SMA 20-
SMA 40-
52-Week High$9.13
52-Week Low$5.34
50-Day Avg$6.65
200-Day Avg$6.87
Avg Volume343.3K
Volume260.9K

Performance Analysis

NEUTRAL

INGN presents a mixed picture with both positive and negative indicators.

~ Trading at 35% of its 52-week range.
~ RSI at 51.7 is in neutral territory.
~ Modest revenue growth of 3.4% year-over-year.
- Operating at a loss with -7.1% margin.
~ Wall Street consensus is "none" from 3 analysts.
+ Average analyst target of $12.67 implies 90.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:15 UTC

Back to Screener Export Report